OPKO Health, Inc.
$1.53B- Market cap
- $1.21B
- Debt
- +$687.93M
- Cash
- −$364.41M
Capital structure 64% equity / 36% debt · EV / Revenue 2.53x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: OPK stock price at premium vs RHI $1.62 current versus $0.66 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at RHI's multiple
Implied fair value · at OPK's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: OPK FY 2025 (ended Dec 31, 2025) · RHI FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 64% equity / 36% debt · EV / Revenue 2.53x
Capital structure 91% equity / 9% debt · EV / Revenue 0.80x · EV / EBITDA 17.53x
RHI carries the larger enterprise value at $4.32B against $1.53B; RHI trades on the lower EV / Revenue multiple (0.80x vs 2.53x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
OPKO Health, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
ROBERT HALF INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.54x
0.33x
Net debt / EBITDA
Leverage against operating earnings
-3.03x
-0.16x
Cash and equivalents
Liquid reserves on the balance sheet
$364.41M
$464.44M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMARIN CORP PLC\UK
OPK vs AMRN
Sarepta Therapeutics, Inc.
OPK vs SRPT
Amphastar Pharmaceuticals, Inc.
OPK vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
OPK vs SUPN
Harmony Biosciences Holdings, Inc.
OPK vs HRMY
ManpowerGroup Inc.
OPK vs MAN
INSPERITY, INC.
OPK vs NSP
Accenture plc
OPK vs ACN
MARSH & MCLENNAN COMPANIES, INC.
OPK vs MMC
$687.93M
$425.96M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.